AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Cipro XR approval. (Products).

OB GYN News

| March 01, 2003 | COPYRIGHT 2003 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Cipro XR (ciprofloxacin) has been approved for treating uncomplicated urinary tract infections caused by Escherichia coli, Proteus mirabilis, Enterococcus faecalis, or ...

Related articles from newspapers, magazines, journals, and more
Bayer submits Cipro XR bid. (Digest).(once-daily modified-release tablet...
Magazine article from: Chain Drug Review November 25, 2002 700+ words
Bayer Corp. has submitted a new drug application to market Cipro XR in a once-daily modified-release tablet formulation for the treatment of urinary tract infections. The new formulation of...
Cipro XR provides rapid symptom improvement in uncomplicated UTIs.
Newspaper article from: Biotech Week November 24, 2004 700+ words
...UTI symptoms within 3 hours of taking Cipro XR, and half of the patients reported significant...of patients at 24 hours upon taking Cipro XR, and 10% at 48 hours after having taken...of Family Medicine. "In this study, Cipro XR was shown to provide fast symptom relief...
FDA approves once-daily Cipro XR.
Newspaper article from: Biotech Week January 15, 2003 700+ words
...Drug Administration (FDA) has approved Cipro XR (ciprofloxacin extended-release tablets...susceptible strains of indicated organisms. Cipro XR will be marketed for use at a dosage strength of 500 mg. Cipro XR was developed using a bilayer matrix...
Once-daily Cipro XR as safe and effective as conventional Cipro.
Newspaper article from: Drug Week February 6, 2004 700+ words
...A new study shows that once-daily Cipro XR (ciprofloxacin extended-release tablets...Urology. Clinical cure occurred in 97% of Cipro XR patients compared with 94% of patients...days of treatment with either 1000 mg Cipro XR taken once daily and 500 mg conventional...
Study results show safety and efficacy profile of once-daily Cipro XR.
Newspaper article from: Drug Week May 30, 2003 700+ words
...results show that once-daily 1000 mg Cipro XR (ciprofloxacin extended-release tablets...The study, which evaluated 1000 mg Cipro XR taken once-daily and 500 mg conventional...demonstrated clinical cure in 97% of Cipro XR patients compared with 94% of patients...
FDA approves once-daily Cipro XR for the treatment of cUTIs.
Newspaper article from: Health & Medicine Week September 22, 2003 700+ words
...approved a once-daily formulation of Cipro XR (ciprofloxacin extended-release tablets...for 7-14 days at a dose of 1000 mg. Cipro XR is specifically formulated to be taken...In December 2002, the FDA approved Cipro XR as a once-daily, 3-day treatment...
FDA approves once-daily Cipro XR for complicated cases.
Newspaper article from: Drug Week September 19, 2003 700+ words
...approved a once-daily formulation of Cipro XR (ciprofloxacin extended-release tablets...mg. The once-a-day convenience of Cipro XR has the potential to contribute to compliance...relapse and subsequent resistant infection. Cipro XR already is used for the treatment of uncomplicated...
Study Comparing Once-Daily Cipro XR to Conventional Twice-Daily Cipro Supports...
Press release article from: Business Wire September 30, 2002 700+ words
...physician visits per year in the US(1). "We developed Cipro XR in direct response to the needs of our customers. We asked...Food and Drug Administration (FDA) in March 2002 to market Cipro XR for the treatment of uncomplicated UTI in the once daily tablet...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA